NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Beijing Kangai Ruihao Biotechnology Co., Ltd.

Beijing Kangai Ruihao Biotechnology Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttp://biohealthcare.com.cn/

Last Round

Private Equity

Jan 25, 2017

Total Funding Raised

$3.71M

Company Overview

Beijing Kangai Ruihao Biotechnology Co., Ltd. is a biopharmaceutical company that focuses on the research, development, and commercialization of cell-based therapies for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

in-vitro diagnosticIVDclinical laboratory equipmentdiagnostic reagentslab supplylaboratory information systemLISmedical device distributionlab automationclinical diagnosticmedical equipment maintenancebiotech supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Kangai Ruihao Biotechnology Co., Ltd. Comparables

Compare Beijing Kangai Ruihao Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Kangai Ruihao Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IASO Bio
36%
Sinocelltech Group Ltd
34%
Bioceltech Therapeutics, Ltd.
33%

Beijing Kangai Ruihao Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJan 25, 2017
Series ADec 1, 2014
AngelMar 19, 2014

Beijing Kangai Ruihao Biotechnology Co., Ltd. Investors

Notable investors and investment history

Beijing Kangai Ruihao Biotechnology Co., Ltd. investors
InvestorRounds
Shenzhen GTJA Investment GroupPrivate Equity
High Ground CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 25, 2017

    $3M round from Shenzhen GTJA Investment Group.

Beijing Kangai Ruihao Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing Kangai Ruihao Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing Kangai Ruihao Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range1
Year Founded2012
Last FundingJan 25, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.